Name
BioVendor Group
Company Description
We are an international group of biotechnology companies with expertise in immunodiagnostics, molecular diagnostics, and radio-immunodiagnostics. Founded in 1992 in the Czech Republic, we have grown from a local company into a global innovator with in-house research, development, and production of in-vitro diagnostic (IVD) products, supported by an international distribution network.
Our portfolio is structured around two complementary diagnostic pillars:

Immunodiagnostics
We provide a broad immunodiagnostic portfolio covering routine and specialized laboratory testing across key technologies.
CLIA
Markers in autoimmunity, diabetes, gastrointestinal diseases and Infectious serology, available exclusively on the KleeYa ® platform, expanding testing possibilities

MBA
Precision multiplex diagnostics for comprehensive antibody detection in autoimmune and infectious diseases.

BLOT
Reliable, robust technology for precise detection of specific antibodies.

ELISA
Complete portfolio for Infectious serology, immunology & endocrinology.

RIA/IRMA
Proved radioimmunoassays for endocrinology including unique niche parameters.

Antibodies
The foundation of immunoassays, driving performance across every diagnostic technology.

Molecular Diagnostics
In molecular diagnostics, BioVendor Group delivers solutions ranging from PCR-based assays to high-precision next-generation sequencing (NGS).

RealFast™️ Assay
IVDR certified real-time PCR assays for rapid detection of clinically relevant genetic variants and CNVs, covering CVD and pharmacogenetics.

StripAssay®
IVDR certified multiplex PCR and hybridization-based assays for simultaneous detection of clinically relevant genetic variants, covering Thalassemia and Cystic Fibrosis.

NGS Assay
Targeted sequencing for oncology, hereditary diseases, and microbiome analysis with integrated bioinformatics.

fastGEN™
One-step PCR NGS library preparation for challenging oncology samples, including
bioinformatic analysis.
Product Categories
OEM Products, Allergy Testing, Autoimmune Disease Testing, Cancer Testing, Cholesterol Testing, Genetic Testing, Infectious Disease Testing, Molecular Diagnostics, Multiplex Testing, Point of Care Testing, Thyroid Testing, Viral Testing, Chemiluminescence Systems, ELISA, Immunoassay Systems, Microarrays, Cancer Markers, Pharmacogenomics, Tumor Markers
Will you have new products this year?
Yes
Business Needs
Distributor/Agent/Representative
Products to be Exported
Immunodiagnostic and molecular diagnostic solutions for clinical and research laboratories, including automated CLIA systems, ELISA kits, Microblot-Array (MBA) assays, immunoblot technologies, PCR and NGS workflows. Portfolio covers autoimmune, endocrinology, infectious disease, oncology and genetic testing applications, supported by bioinformatics and data analysis solutions for modern laboratory workflows.
Address
Karasek 1
Brno, 62100
Czech Republic
LinkedIn

Listings

Relevance
BioVendor Group Showcases Expanding Molecular Diagnostics Portfolio at ADLM 2026
Microblot-Array Liver Profile kit: IVDR-certified and officially launched
Expanding diabetes diagnostics with a fully automated CLIA solution

Share: